This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Biliary atresia is a rare condition in which the bile ducts between the liver and gallbladder are either blocked or absent. This condition can occur in babies as early as the first week of life and is the most common cause of biliary cirrhosis in children. Symptoms of biliary atresia vary depending on the severity of the condition, but can include jaundice, dark urine, pale stools, failure to thrive, and enlarged liver and spleen. The cause of biliary atresia is still unknown, but it is believed to be due to an immune reaction or a virus that causes the bile ducts to become inflamed and scarred. In some cases, it can be linked to a genetic disorder, such as alpha-1-antitrypsin deficiency. Diagnosis is usually made through a combination of physical examination, imaging tests such as an ultrasound or MRI, and blood tests. In some cases, a liver biopsy may be needed to confirm the diagnosis. Treatment typically involves surgery to construct a new bile duct and remove any existing scar tissue. In some cases, a liver transplant may be needed if the condition has progressed too far. In general, with proper diagnosis and treatment, the outcome of biliary atresia is usually good. However, it is important to monitor for any long-term complications, such as cirrhosis, liver failure, and bile duct cancer. Regular liver function tests, imaging tests, and physical exams are important for monitoring the condition.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States